BackENDRA Life Sciences Overview

ENDRA Life Sciences Current Cash

Track ENDRA Life Sciences's current cash ($1.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$1.74M
3.79% YoYΔ $-68631.00 vs prior year quarter

Peer trimmed avg / median

Loading

ENDRA Life Sciences Current Cash History

Loading

ENDRA Life Sciences vs. peers: Current Cash Comparison

Loading

ENDRA Life Sciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

ENDRA Life Sciences (NDRA) FAQ

As of the most recent data (June 2026), NDRA shows a current cash of $1.7M. That compares with $1.8M in the prior-year period — down 3.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NDRA's current cash is now $1.7M (was $1.8M) — a 3.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether ENDRA Life Sciences is outperforming or lagging.

Tracking NDRA's current cash over time shows whether ENDRA Life Sciences is scaling, shrinking, or reshaping that part of the business. The current reading is $1.7M That compares with $1.8M in the prior-year period — down 3.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has ENDRA Life Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $1.7M) with ownership activity and broader fundamentals.

ENDRA Life Sciences's current cash is $1.7M; compare it with other Technology names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.